The costs and underappreciated consequences of research misconduct: A case study

PLoS Medicine

Volumn 7, Issue 8, 2010, Pages

  Michalek, Arthur M ^a   Hutson, Alan D ^a   Wicher, Camille P ^a   Trump, Donald L ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCOUNTING; ARTICLE; CASE STUDY; COST BENEFIT ANALYSIS; FORGERY; HEALTH CARE COST; HEALTH CARE FINANCING; MEDICAL RESEARCH; PRODUCTIVITY; PROFESSIONAL PRACTICE; SCIENTIFIC MISCONDUCT; STATISTICAL ANALYSIS; COST; ECONOMICS; HEALTH SERVICES RESEARCH; HUMAN; LEGAL ASPECT; NATIONAL HEALTH ORGANIZATION; UNITED STATES;

COSTS AND COST ANALYSIS; HUMANS; NATIONAL CANCER INSTITUTE (U.S.); ORGANIZATIONAL CASE STUDIES; SCIENTIFIC MISCONDUCT; UNITED STATES;

EID: 77956865041     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000318     Document Type: Article

References (4)

1. Department of Health and Human Services (17 May 2005) 42CFR Parts 50 and 93, Public Health Service Policies on Research Misconduct; Final Rule. Federal Register.
2. namegr typeauthornamesnameFanelli/snamex /xfnameD/fname/name/namegr (2009) How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS One 4: e5738.
3. Shafer S (2009) Tattered threads. Anesth Analg 108: 1361-1363.
4. Reich ES (2009) The Specter of Fraud. Scientific American 301: 24-25.